Search research articles
Contact Us
Filters
Showing results (21-30 of 96) with videos related to
Page
of 10
Sort By:
Antimicrobial Agents and Chemotherapy
|
October 18, 2006
Effect of anaerobic growth on quinolone lethality with Escherichia coli
Muhammad Malik, Syed Hussain, Karl Drlica
The New England Journal of Medicine
|
July 10, 2002
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia
Glenn S Tillotson, Xilin Zhao, Karl Drlica
The Journal of Antimicrobial Chemotherapy
|
November 22, 2012
Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae
Kelli Metzler, Karl Drlica, Joseph M Blondeau
The Journal of Antimicrobial Chemotherapy
|
January 14, 2010
Contribution of reactive oxygen species to pathways of quinolone-mediated bacterial cell death
Xiuhong Wang, Xilin Zhao, Muhammad Malik, et al.
Mbio
|
October 26, 2017
Tuning of the Lethal Response to Multiple Stressors with a Single-Site Mutation during Clinical Infection by <i>Staphylococcus aureus</i>
Krishan Kumar, John Chen, Karl Drlica, et al.
The Annals of Pharmacotherapy
|
September 2, 2004
The changing face of antibiotic prescribing: the mutant selection window
Benjamin J Epstein, John G Gums, Karl Drlica
Antimicrobial Agents and Chemotherapy
|
August 28, 2013
Superoxide-mediated protection of Escherichia coli from antimicrobials
Michael Mosel, Liping Li, Karl Drlica, et al.
Plos One
|
September 8, 2011
A toxin-antitoxin module in Bacillus subtilis can both mitigate and amplify effects of lethal stress
Xiangli Wu, Xiuhong Wang, Karl Drlica, et al.
Antimicrobial Agents and Chemotherapy
|
December 13, 2017
Suppression of Reactive Oxygen Species Accumulation Accounts for Paradoxical Bacterial Survival at High Quinolone Concentration
Gan Luan, Yuzhi Hong, Karl Drlica, et al.
The Journal of Antimicrobial Chemotherapy
|
September 28, 2006
Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli
Xilin Zhao, Brian Quinn, Robert Kerns, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 96) with videos related to
Sort By:
Page
of 10
Antimicrobial Agents and Chemotherapy
|
October 18, 2006
Effect of anaerobic growth on quinolone lethality with Escherichia coli
Muhammad Malik, Syed Hussain, Karl Drlica
The New England Journal of Medicine
|
July 10, 2002
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia
Glenn S Tillotson, Xilin Zhao, Karl Drlica
The Journal of Antimicrobial Chemotherapy
|
November 22, 2012
Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae
Kelli Metzler, Karl Drlica, Joseph M Blondeau
The Journal of Antimicrobial Chemotherapy
|
January 14, 2010
Contribution of reactive oxygen species to pathways of quinolone-mediated bacterial cell death
Xiuhong Wang, Xilin Zhao, Muhammad Malik, et al.
Mbio
|
October 26, 2017
Tuning of the Lethal Response to Multiple Stressors with a Single-Site Mutation during Clinical Infection by <i>Staphylococcus aureus</i>
Krishan Kumar, John Chen, Karl Drlica, et al.
The Annals of Pharmacotherapy
|
September 2, 2004
The changing face of antibiotic prescribing: the mutant selection window
Benjamin J Epstein, John G Gums, Karl Drlica
Antimicrobial Agents and Chemotherapy
|
August 28, 2013
Superoxide-mediated protection of Escherichia coli from antimicrobials
Michael Mosel, Liping Li, Karl Drlica, et al.
Plos One
|
September 8, 2011
A toxin-antitoxin module in Bacillus subtilis can both mitigate and amplify effects of lethal stress
Xiangli Wu, Xiuhong Wang, Karl Drlica, et al.
Antimicrobial Agents and Chemotherapy
|
December 13, 2017
Suppression of Reactive Oxygen Species Accumulation Accounts for Paradoxical Bacterial Survival at High Quinolone Concentration
Gan Luan, Yuzhi Hong, Karl Drlica, et al.
The Journal of Antimicrobial Chemotherapy
|
September 28, 2006
Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli
Xilin Zhao, Brian Quinn, Robert Kerns, et al.
Page
of 10